AQR Capital Management LLC Has $6.88 Million Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

AQR Capital Management LLC boosted its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 27.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 327,418 shares of the company's stock after acquiring an additional 71,150 shares during the quarter. AQR Capital Management LLC owned 0.81% of Phibro Animal Health worth $6,876,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Aquatic Capital Management LLC bought a new position in shares of Phibro Animal Health during the fourth quarter worth approximately $69,000. Quantbot Technologies LP lifted its holdings in shares of Phibro Animal Health by 65.1% during the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock worth $107,000 after acquiring an additional 2,018 shares during the period. Meeder Asset Management Inc. bought a new position in Phibro Animal Health in the fourth quarter valued at approximately $113,000. New York State Teachers Retirement System raised its position in Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares in the last quarter. Finally, Nebula Research & Development LLC bought a new stake in Phibro Animal Health during the fourth quarter worth $210,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Trading Up 1.0 %

PAHC traded up $0.23 during trading on Friday, reaching $22.48. 317,954 shares of the stock traded hands, compared to its average volume of 194,137. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The stock's 50-day moving average is $19.99 and its 200 day moving average is $21.84. Phibro Animal Health Co. has a 12 month low of $16.16 and a 12 month high of $26.55. The stock has a market capitalization of $910.51 million, a PE ratio of 46.83, a P/E/G ratio of 0.45 and a beta of 0.62.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.52 by $0.11. The business had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Equities analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.14%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio is presently 100.00%.

Analysts Set New Price Targets

Several brokerages have commented on PAHC. Barclays boosted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. StockNews.com raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday. Finally, Morgan Stanley boosted their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research note on Thursday. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $20.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.